Please login to the form below

Not currently logged in

CanSino Biologics

This page shows the latest CanSino Biologics news and features for those working in and with pharma, biotech and healthcare.

Sinovac begins late-stage COVID-19 vaccine trial

Sinovac begins late-stage COVID-19 vaccine trial

Another Chinese biotech company, CanSino Biologics, also recently announced the launch of a phase 3 clinical trial of its COVID-19 vaccine candidate Ad5-nCOV in Saudi Arabia.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The volunteers will be isolated for 14 days after being dosed with the adenovirus-based Ad5-nCoV shot, which was developed in collaboration with CanSino Biologics, and will then be monitored

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...